A citation-based method for searching scientific literature

J Dupre, M T Behme, I M Hramiak, P McFarlane, M P Williamson, P Zabel, T J McDonald. Diabetes 1995
Times Cited: 121







List of co-cited articles
1236 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
30




Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
A Wettergren, B Schjoldager, P E Mortensen, J Myhre, J Christiansen, J J Holst. Dig Dis Sci 1993
528
25

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.
L A Scrocchi, T J Brown, N MaClusky, P L Brubaker, A B Auerbach, A L Joyner, D J Drucker. Nat Med 1996
575
25


Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
23




Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
D A Stoffers, T J Kieffer, M A Hussain, D J Drucker, S Bonner-Weir, J F Habener, J M Egan. Diabetes 2000
453
21


Glucagon-like peptide 1 improved glycemic control in type 1 diabetes.
Margaret T Behme, John Dupré, Thomas J McDonald. BMC Endocr Disord 2003
53
37





Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Yazhou Li, Tanya Hansotia, Bernardo Yusta, Frederic Ris, Philippe A Halban, Daniel J Drucker. J Biol Chem 2003
462
18

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
M A Nauck, U Niedereichholz, R Ettler, J J Holst, C Orskov, R Ritzel, W H Schmiegel. Am J Physiol 1997
509
17

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
913
17

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski. J Clin Invest 1998
190
17


Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes.
John Dupré, Margaret T Behme, Thomas J McDonald. J Clin Endocrinol Metab 2004
92
18




Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
617
16



Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Bo Ahrén, Erik Simonsson, Hillevi Larsson, Mona Landin-Olsson, Hlin Torgeirsson, Per-Anders Jansson, Madeléne Sandqvist, Peter Båvenholm, Suad Efendic, Jan W Eriksson,[...]. Diabetes Care 2002
340
16

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
470
16

GLP-1 does not not acutely affect insulin sensitivity in healthy man.
L Orskov, J J Holst, J Møller, C Orskov, N Møller, K G Alberti, O Schmitz. Diabetologia 1996
108
15

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.
N Imeryüz, B C Yeğen, A Bozkurt, T Coşkun, M L Villanueva-Peñacarrillo, N B Ulusoy. Am J Physiol 1997
261
15


Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers.
C M Edwards, S A Stanley, R Davis, A E Brynes, G S Frost, L J Seal, M A Ghatei, S R Bloom. Am J Physiol Endocrinol Metab 2001
350
15

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Michael A Nauck, Markus M Heimesaat, Kai Behle, Jens J Holst, Markus S Nauck, Robert Ritzel, Michael Hüfner, Wolff H Schmiegel. J Clin Endocrinol Metab 2002
401
15



Gastric emptying and release of incretin hormones after glucose ingestion in humans.
J Schirra, M Katschinski, C Weidmann, T Schäfer, U Wank, R Arnold, B Göke. J Clin Invest 1996
317
14






Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
M Tang-Christensen, P J Larsen, R Göke, A Fink-Jensen, D S Jessop, M Møller, S P Sheikh. Am J Physiol 1996
444
13


The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
D Elahi, M McAloon-Dyke, N K Fukagawa, G S Meneilly, A L Sclater, K L Minaker, J F Habener, D K Andersen. Regul Pept 1994
244
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.